Last updated: February 25, 2026
What Is NDC 55111-0798?
NDC 55111-0798 refers to a specific drug product. The manufacturer and formulation details are as follows:
- Manufacturer: Sun Pharmaceutical Industries Ltd.
- Product Name: Sun Pharma's Generic Aspirin
- Dosage: 81 mg (baby aspirin)
- Packaging: 100-count bottles
This product is a generic aspirin used primarily for cardiovascular prophylaxis, pain relief, and anti-inflammatory purposes.
Market Overview
Product Classification
- Drug Class: Salicylates
- Therapeutic Use: Cardiovascular health, pain, inflammation
- Market Status: Over-the-counter (OTC) and prescription in some regions
Market Size and Trends
The global aspirin market was valued at approximately USD 1.2 billion in 2022, with a compound annual growth rate (CAGR) of 3.2% projected through 2028 [1].
The U.S. constitute roughly 60% of the global aspirin market, driven by aging populations and high cardiovascular disease prevalence.
Competitive Landscape
Major competitors include Bayer, Mylan, and Hikma; generic options dominate the OTC segment, with multiple manufacturers competing on price and formulation.
Regulatory Environment
The product falls under OTC regulations by the FDA in the United States, with manufacturing practices governed by Good Manufacturing Practices (GMP). Patent exclusivity for innovator brands expired decades ago, enabling broad generic entry.
Price Trends and Projections
Current Pricing
- Average wholesale acquisition cost (WAC): USD 3.50 for a 100-count bottle of 81 mg aspirin.
- Retail price: USD 7.50 - USD 10 after markup.
- Typical consumer retail price: USD 0.075 per tablet.
Factors Influencing Price Change
- Increased manufacturing efficiencies reduce costs.
- Market saturation limits price increases.
- Supply chain disruptions could influence availability and price.
- Regulatory shifts affecting OTC sales.
Price Projection (Next 3-5 Years)
| Year |
Projected WAC (USD) |
Consumer Price (USD per bottle) |
Remarks |
| 2023 |
3.50 |
7.50 |
Stable pricing, high competition |
| 2024 |
3.40 |
7.25 |
Slight decrease due to efficiency |
| 2025 |
3.30 |
7.00 |
Similar market trends |
| 2026 |
3.25 |
6.75 |
Potential price stabilization |
| 2027 |
3.20 |
6.50 |
Market saturation persists |
Realistic expectations do not foresee significant price hikes unless supply chain disruptions or regulatory changes occur.
Key Market Drivers and Risks
Drivers
- High prevalence of cardiovascular disease.
- Growing acceptance of OTC medications for chronic use.
- Price sensitivity in OTC segment benefits from generic competition.
Risks
- Market saturation and price compression.
- Regulatory hurdles, e.g., changes in OTC labeling.
- Potential supply chain disruptions affecting availability.
Strategic Implications
Manufacturers should focus on cost efficiencies to maintain margins as price competition intensifies. Entry strategies for new competitors include offering competitive pricing and emphasizing product quality.
Key Takeaways
- NDC 55111-0798 is a generic aspirin product with a stabilized market.
- The U.S. market dominates, with a projected steady but modest price decline through 2027.
- Market saturation and low product differentiation limit price growth.
- Price competition remains fierce, with minor fluctuations driven by manufacturing efficiencies.
- External factors like supply disruptions or regulatory shifts could alter long-term projections.
FAQs
1. How does the price of NDC 55111-0798 compare to branded aspirin?
Generic aspirin typically costs 70-80% less than branded options like Bayer Aspirin.
2. Are there significant regulatory barriers for manufacturers of this product?
No; OTC aspirin is widely approved. Manufacturing must meet GMP standards, but no patent restrictions exist.
3. What factors could cause price increases in the future?
Supply chain disruptions, raw material shortages, or regulatory changes affecting OTC drug availability.
4. Is there potential for newer formulations to impact this market?
Limited; standard low-dose aspirin has decades of established use. New formulations are unlikely to significantly impact pricing.
5. How does market penetration vary across regions?
High in North America, moderate in Europe, limited in Asia due to regional OTC regulations.
References
[1] Grand View Research. (2023). Aspirin Market Size, Share & Trends analysis.
